Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06060444 · ClinicalTrials.gov registry record · NA
Evaluating a Telemedicine Neurological Consult Program for Drug-Induced Movement Disorders Using the RE-AIM Framework
A NA study of Drug-Induced Movement Disorder, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT06060444 is a NA study of Drug-Induced Movement Disorder that has completed, run by University of Vermont. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06060444, a NA study of Drug-Induced Movement Disorder, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
In this pilot study, the investigators will evaluate care delivery via telemedicine to individuals with drug-induced movement disorders (DIMDs). DIMDs can be disabling, and prevention is important; but these disorders are often under-reported, under-recognized and poorly managed. Interprofessional telemedicine for movement disorders is feasible and may provide similar care as in-person visits; however, the majority of studies to date have shown benefit in Parkinson's disease and further validation in other movement disorders is necessary. In this randomized controlled trial the aim is to study the acceptability, feasibility, and patient and clinician outcomes when a neurological consultation is provided for patients with DIMDs either in-person or through telemedicine. The investigators will apply the evaluation framework RE-AIM (Reach and Effectiveness, Adoption, Implementation, and Maintenance) to comprehensively assess the factors that may impact study success and program implementation. Mixed methods will be implemented to gather outcome data from mental health clinicians that refer patients and the patient participants.
Conditions Studied
Interventions
- OTHER Telemedicine Consult
- OTHER In-person Consult
Study Locations (1)
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-04-26 |
| Est. Completion | 2024-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06060444
The ClinicalTrials.gov registry entry for NCT06060444 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Drug-Induced Movement Disorder appearing as the primary indexed condition, and to 2 interventions - of which Telemedicine Consult is the first listed.
NCT06060444 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.
Frequently Asked Questions
What is clinical trial NCT06060444 about?
NCT06060444 is a clinical study titled "Evaluating a Telemedicine Neurological Consult Program for Drug-Induced Movement Disorders Using the RE-AIM Framework". In this pilot study, the investigators will evaluate care delivery via telemedicine to individuals with drug-induced movement disorders (DIMDs). DIMDs can be disabling, and prevention is important; but these disorders are often under-reported, under-recognized and poorly managed. Interprofessional t...
What is the current status of trial NCT06060444?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-04-26. Estimated completion is 2024-10-31.
What conditions does trial NCT06060444 study?
This clinical trial studies the following conditions: Drug-Induced Movement Disorder.
What interventions are being tested in trial NCT06060444?
The interventions under investigation include: Telemedicine Consult (OTHER), In-person Consult (OTHER).
Who is sponsoring clinical trial NCT06060444?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06060444 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.